ALLENA PHARMACEUTICALS INC's ticker is ALNA and the CUSIP is 018119107. A total of 42 filers reported holding ALLENA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 3.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $125,000 | +28.9% | 17,743 | 0.0% | 0.00% | – |
Q4 2018 | $97,000 | -49.2% | 17,743 | 0.0% | 0.00% | – |
Q3 2018 | $191,000 | -17.3% | 17,743 | 0.0% | 0.00% | – |
Q2 2018 | $231,000 | +145.7% | 17,743 | +108.9% | 0.00% | – |
Q1 2018 | $94,000 | +10.6% | 8,495 | 0.0% | 0.00% | – |
Q4 2017 | $85,000 | – | 8,495 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Deer VII & Co. Ltd. | 2,263,365 | $24,309,000 | 36.46% |
Pharmstandard International S.A. | 873,031 | $9,376,000 | 32.28% |
TRV GP II, LLC | 2,790,964 | $29,975,000 | 17.60% |
FRAZIER MANAGEMENT LLC | 3,330,373 | $35,768,000 | 6.55% |
Partner Investment Management, L.P. | 301,889 | $3,242,000 | 2.48% |
SPHERA FUNDS MANAGEMENT LTD. | 295,199 | $3,170,000 | 0.36% |
PFM Health Sciences, LP | 1,768,568 | $18,994,000 | 0.28% |
Perceptive Advisors | 250,000 | $2,685,000 | 0.07% |
NEEDHAM INVESTMENT MANAGEMENT LLC | 4,616 | $200,000 | 0.06% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 83,200 | $894,000 | 0.01% |